FindTrial
Sign In

The application of 5% atomized lidocaine administered via the laryngeal in general anesthesia combined with caudal block in neonates on the concept of ERAS

The application of 5% atomized lidocaine administered via the laryngeal in general anesthesia combined with caudal block in neonates on the concept of ERAS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012576
Enrollment
Unknown
Registered
2017-09-05
Start date
2017-09-20
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia of neonates

Interventions

A:5% atomized lidocaine administered via laryngeal
B:None

Sponsors

Chengdu Women & Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligible criteria included neonates,gestational weeks> 33,scheduled for lower abdominal surgery

Exclusion criteria

Exclusion criteria: Neonates with central nervous system (CNS) disorder, contraindication to caudal block, congenital heart diseases or coagulation disorders were excluded.

Design outcomes

Primary

MeasureTime frame
extubation time;length of surgery intensive care unit stay;hospitalized cost;Intraoperative blood gas;—

Secondary

MeasureTime frame
duration of anesthesia;perioperative complications;—

Countries

China

Contacts

Public ContactYu Cui

Chengdu Women & Children's Central Hospital

105180782@qq.com+86 18040308150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026